ASRS
SRPT icon

Arizona State Retirement System’s Sarepta Therapeutics SRPT Stock Holding History

Arizona State Retirement System’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$495K Buy
27,521
+178
+0.7% +$3.37K ﹤0.01% 1546
2026
Q1 		$595K Sell
27,343
-358
-1% -$6.93K ﹤0.01% 1374
2025
Q4 		$596K Buy
27,701
+1,536
+6% +$32.4K ﹤0.01% 1377
2025
Q3 		$504K Buy
26,165
+717
+3% +$12.8K ﹤0.01% 1510
2025
Q2 		$435K Buy
25,448
+829
+3% +$35.4K ﹤0.01% 1530
2025
Q1 		$1.57M Sell
24,619
-271
-1% -$28.5K 0.01% 839
2024
Q4 		$3.03M Buy
24,890
+394
+2% +$48.3K 0.02% 576
2024
Q3 		$3.06M Buy
24,496
+849
+4% +$117K 0.02% 581
2024
Q2 		$3.74M Buy
23,647
+509
+2% +$65.4K 0.02% 479
2024
Q1 		$3M Buy
23,138
+974
+4% +$119K 0.02% 561
2023
Q4 		$2.14M Sell
22,164
-380
-2% -$36.5K 0.02% 666
2023
Q3 		$2.73M Buy
22,544
+1,538
+7% +$174K 0.02% 541
2023
Q2 		$2.41M Sell
21,006
-1,885
-8% -$243K 0.02% 596
2023
Q1 		$3.16M Buy
22,891
+652
+3% +$84.6K 0.03% 516
2022
Q4 		$2.88M Sell
22,239
-350
-2% -$40.6K 0.03% 514
2022
Q3 		$2.5M Buy
22,589
+171
+0.8% +$17.2K 0.03% 544
2022
Q2 		$1.68M Buy
22,418
+57
+0.3% +$4.19K 0.02% 702
2022
Q1 		$1.75M Buy
22,361
+1,946
+10% +$149K 0.01% 764
2021
Q4 		$1.84M Sell
20,415
-228
-1% -$19.5K 0.01% 779
2021
Q3 		$1.91M Buy
20,643
+134
+0.7% +$10.3K 0.02% 741
2021
Q2 		$1.59M Sell
20,509
-1,106
-5% -$83.8K 0.01% 851
2021
Q1 		$1.61M Buy
21,615
+229
+1% +$21.1K 0.01% 833
2020
Q4 		$3.65M Sell
21,386
-1,157
-5% -$171K 0.03% 478
2020
Q3 		$3.17M Buy
22,543
+5,332
+31% +$810K 0.03% 477
2020
Q2 		$2.76M Buy
17,211
+57
+0.3% +$7.76K 0.04% 403
2020
Q1 		$1.68M Buy
+17,154
New +$1.96M 0.03% 515

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Arizona State Retirement System's SRPT Position: Q2 2026 in Review

Arizona State Retirement System increased its Sarepta Therapeutics (SRPT) stake by 0.65% in Q2 2026, buying an estimated $3.37K and bringing the position to 27,521 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Arizona State Retirement System first reported a position in SRPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.74M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Arizona State Retirement System held 27,521 shares of Sarepta Therapeutics worth $495K as of Q2 2026.
  • Arizona State Retirement System bought 178 Sarepta Therapeutics shares in Q2 2026, an estimated $3.37K.
  • Sarepta Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1546 holding.
  • Arizona State Retirement System first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's Sarepta Therapeutics position peaked at $3.74M in Q2 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.